Cotinine Screening Devices Market Outlook (2022 to 2032)

The global cotinine screening devices market recorded sales worth US$ 429.9 Million in the year 2021. The market is expected to expand at a cumulative CAGR of 4.7% and will grow 1.4X by the end of 2032, in which the sales are anticipated to be worth US$ 645 Million. This growth can be attributed to the following factors:

  • Rising usages of cotinine screening devices in various workspaces
  • The significance of cotinine screening tools as important risk indicators in life insurance tests
  • Regional governments introducing smoking cessation initiatives
Data Points Market Insights
Market Value 2022 US$ 450.3 Million
Market Value 2032 US$ 645 Million
CAGR 2022 to 2032 4.7%
Share of top 5 countries 71.9%
Key Players The Key players in the Cotinine Screening Devices market are Abbott Laboratories; AlcoPro; Jant Pharmacal Corporation; Sinocare Inc.; Mossman Associates; Nano-Ditech Corp; LifeSign LLC; ALFA Scientific; Ameritek USA.; Hangzhou Clongene Biotech Co.; and Germaine Laboratories; Inc.

New Developments are enhancing Demand in the Global Market

High-performance Thin Layer Chromatography (HPTLC) has become a successful method for the creation and measurement of biomarkers. A significant development in the healthcare sector is the adoption of HPTLC as a reliable screening node for cotinine. The resurrected usage of HPTLC will open up new business prospects for manufacturers of cotinine screening equipment across the world.

The global market for cotinine screening devices is predicted to have greater competition over the coming ten years. The increased need for better methods of analyzing and diagnosing lung disorders has created new market possibilities for vendors. Another potential possibility for manufacturers is the use of cotinine in forensic testing and analysis.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Smoking Cessation campaigns to boost the use of these devices

Campaigns aimed at quitting smoking encourage people to try quitting smoking several times. These initiatives also seek to raise awareness of the many methods of quitting. Through these efforts, the negative effects of continued smoking are also emphasized.

People now have more information regarding nicotine and tobacco's ingredients. To monitor their health, people willingly undergo cotinine testing. Therefore, it is anticipated that cotinine screening tools will become more common in the next few years. To combat the growing prevalence of smoking habits, the medical community has partnered with top pharmaceutical firms. Long-term smoking's impacts on human lungs have emerged as a major field of study in medicine.

Cotinine is becoming crucial for Medical Treatments:

The fact that the alkaloid is widely used to treat PTSD is important from the standpoint of the growing market. Additionally, employing cotinine to treat mental illnesses has grown to be a well-known practice in the healthcare sector.

Cotinine aids in the management and control of schizophrenia and other conditions of a similar kind. Therefore, it is reasonable to anticipate that the world market for cotinine screening equipment will follow an upward development trajectory.

Cotinine Screening Devices Market

The USA to dominate the Global Cotinine Screening Devices Market during 2022 to 2032

According to the American Lung Association, smoking is the primary factor in 1 out of every 5 fatalities in the country. Serious health problems are being caused by the growing number of adults and kids who smoke. In America, about 14% of individuals have a smoking addiction. The American Lung Association, therefore, imposes a national cigarette tax as well as other tobacco product taxes to control the use of tobacco and nicotine content.

In 2020, the typical state cigarette tax was about US$ 1.82 per pack. Additionally, the American Lung Association developed health insurance plans, initiatives, and policies for smoke-free workplace regulations. These elements support the development of cotinine screening tools. Thus, in 2021, the United States of America had the greatest penetration rate for cotinine screening equipment.

In the year 2021, the cotinine screening devices market accounted for 8.1 percent of the global drug screening market, with sales of $ 5.3 billion. Increased use of cotinine screening devices in the workplace, the importance of drug-free recruiting, and the need for screening devices in insurance calculations are just a few of the important drivers driving this market's growth.

Cotinine is an alkaloid substance, formed in the human body after the consumption of nicotine. Cotinine is used for testing substance abuse in people because it stays in the human body for approximately 8 to 10 days. Cotinine is a biomarker indicating tobacco use.

Mandatory cotinine screening tests to hire employees is expected to rise the number of tests as well as products requirement in the market The sporting events have added nicotine to the list of drugs to be screened which is anticipated to propel the demand for cotinine screening devices around the world. Random checking of students at schools in North America as well as in East Asia also adds up to the growing demand for these devices. Moreover, compulsory screening of armed forces personnel before induction is another reason generating the demand for cotinine screening devices around the world over the forecast period.

The contract manufacturing of Cotinine screening devices in emerging countries is rising and favoring revenue generation for the key players. Marketing rights of manufacturers are undertaken by marketing entities to increase the promotion of cotinine screening devices, along with the license of available products to distribute exclusively in the other markets. The direct presence through the deployment of the salesforce in remote and smaller markets is one of the actions taken by players to increase the demand for these devices. E-Commerce and online trading through portals accessing online payment also attributes to the rising adoption of these devices for the detection of substance abuse.

Cassettes held a 62.9% market share, by the value of the overall cotinine screening devices market in the year 2021 and are expected to grow at a cumulative CAGR of 5.1% and will record sales worth US$ 645 Million by the end of 2032. The growing tobacco use amongst the younger generation is one of the key factors which is fueling the demand for cotinine screening devices market around the globe.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 4.69%
H1, 2022 Projected 4.71%
H1, 2022 Outlook 4.61%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 9 ↓

FMI delivers a comparative study of the global cotinine screening devices market's growth rates and development prospects. As a result of the impact of macro and industrial variables, the market is influenced by an increase in the patient base and product adoption rate.

Contract manufacturing of cotinine screening devices in emerging nations, and the introduction of e-commerce, and online trading with accessible online payment for such devices are all important trends in this market.

According to FMI, the market growth rate of cotinine screening devices is expected to decline by 09 Basis Point Share (BPS) in H1-2022 compared to H1-2021. Further comparison between the values for the H1-2022 outlook and H1-2022 projected showed a dip of 10 BPS.

Due to the lack of evaluation of inexpensive single-line test strips for cotinine screening, key aspects associated with the lowering of BPS are attributed to the differential qualitative dichotomization of smokers and non-smokers.

The importance of cotinine screening devices as significant indications of risk in life insurance testing, as well as the introduction of smoking cessation programs by regional governments, are two positives for the sector.

2014 to 2021 Cotinine Screening Devices Demand Outlook Compared to 2022 to 2032 Forecast

According to Future Market Insights, the cotinine screening devices market expanded at a cumulative CAGR of 4.2% between 2014 and 2021. The market grew 1.3X during this period and is expected to follow a similar trend over the forecast period.

According to the Centre for Disease Control and Prevention, approximately 34.1 million people in the USA smoked cigarettes in the year 2019. Along with the use of regular cigarettes, the use of vaping or electronic cigarettes has been on the rise in the past few years as well. According to a survey conducted in the USA, it was estimated that by the end of 2021, around 55 million people would be using e-cigarettes in the world.

As per CDC, around 33% of women smokers under Medicaid deny the use of tobacco during pregnancy. A recent study carried out indicated that a higher percentage of low-income pregnant women have a positive opinion about using urine cotinine tests to promote smoking cessation during pregnancy. The study also finds out that close to 90% of pregnant women favor nicotine testing during pregnancy but also fear if cotinine tests positive.

Various functional attributes of these screening devices give them a competitive edge over laboratory-based cotinine screening techniques, such as ease of use, convenience, and cost-effectiveness. These factors will help cotinine screening devices to gain preference in the world. These screening devices are also preferred by insurance providers, the majority used in smoking cessation programs and rehabilitation centers.

The cotinine screening devices are portable, which reduces the cost of logistics such as sample handling, sample delivery to the laboratories, generation of reports, etc. These devices also reduce the time taken in screening as they give the results within a few minutes. These devices can be used anywhere according to the preference of the consumers, which also improves the adoption rate. All these factors are constantly propelling the demand for this market around the globe.

Manufacturers are concentrating their efforts on developing cotinine screening equipment that is simple to use and provides quick findings. Manufacturers are responding to the sensitivities around distinct end-use cases by producing devices with features that comply with appropriate regulatory standards. The major players in the cotinine screening devices market are competing to increase the production of cassettes and strips, as these are the two most 'in-demand' forms.

The key players in this industry are entering into strategic agreements and partnerships acquiring subsidiaries to enhance their market presence and expand into the diagnostic testing market around the world.

In May 2018, AlcoPro Inc., a drug and alcohol testing products company announced the acquisition of Kahntact USA to improve its market presence around the world.

In June 2019, PTS Diagnostics announced their co-branded agreement with eTrueNorth, which is an integrated pharmacy-based clinical services network to enhance their services and close the gaps in healthcare and wellness screenings.

In January 2020, Jant Pharmacal Corporation announced the procurement of a contract with Vizient Inc., for their entire line of rapid test kits.

The cotinine screening devices market is consolidated with players such as Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc.

Future Market Insights expects the global cotinine screening devices market to expand at a cumulative CAGR of 4.7% over the forecast period (2022 to 2032) owing to the efforts taken by the key players to expand in the global market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What are the opportunities for various manufacturers of the cotinine screening devices industry?

The growing number of smokers worldwide is expected to provide high growth opportunities for test providers and cotinine screening device manufacturers. According to the National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs together create an economic burden of nearly US$ 700 billion in the USA through related costs, lost work productivity, and healthcare, which represents a vast opportunity for market growth.

Technological advances related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to create high demand for cotinine screening products. Manufacturers are focusing on using samples other than urine, such as saliva and hair samples, which is less embarrassing for individuals being tested.

What are the restraining factors for this market?

The decrease in the reimbursement rate for undergoing tobacco abuse testing may hamper the revenue growth of the stakeholders in the cotinine screening devices market. For instance in June 2015 Centers for Medicare and Medicaid Services reduced the reimbursement coverage to only two G codes for drug abuse testing, one for presumptive testing and one for definitive testing. The decrease in reimbursement may directly influence the number of drug abuse tests performed in the USA, as low reimbursement would lead to out-of-pocket spending for the customers. Although the cost of cotinine screening devices is low as compared to the other drug abuse testing devices cotinine testing volume can also be affected adversely with an overall decrease in the drug abuse reimbursement as many cotinine screening tests are performed as part of drug abuse testing.

The adoption of cotinine testing is limited to the general population for evaluation. Although various healthcare facilities carry out cotinine testing on regular basis for their employees many of them exclude current employees from it and carry out screening on new employees in the facility. Despite many employers across various countries adopting cotinine screening, the pace at which the adoption is rising is much slower compared to other screening tests used for drug abuse. The lack of immediate adverse effects makes cotinine testing’s importance go unnoticed by various employers. Low adoption of cotinine testing in rehabilitation centers as well is another reason, which may limit the growth of the market.

Country-wise Insights

Will the USA remain a key market for cotinine screening devices?

The American Lung Association has been playing a major role in the lives of people helping them to quit smoking. Their program Freedom From Smoking® has helped people for 35 years and is ranked one of the best tobacco cessation programs in the world. Other programs such as Smokefree, and Quit for Life also operate in the USA The more efforts taken by the government as well as non-profit organizations in the country to stop tobacco use are attributed to the high share of the USA in the cotinine screening devices market in North America. The USA accounted for 97.0% of the market share, by the value of the total market in North America in the year 2021.

How does the cotinine screening devices market look in Germany?

Around 28% of the population, aged 15 and more in Germany smoked cigarettes regularly, in the year 2018. The government of Germany laid down some laws to curb smoking and protect the non-smoking people and the country such as The protection of Young Persons Act and the Federal Non-smokers protection act. These laws and other smoking cessation efforts which are taken by the government fuel the demand for cotinine screening devices in Germany. The sales of this market were recorded to be US$ 40.0 Million in the year 2021, and the market is expected to grow at a cumulative CAGR of 4.9% over the forecast period in Germany.

Why does India hold the highest market share in the South Asia cotinine screening devices market?

According to the WHO tobacco statistics of India, the economic burden attributed to tobacco use in India during the year 2018 accounted for US$ 27. 5 Billion. Nearly 29% of India’s population regularly smoked cigarettes or some other form of tobacco in the same year, which made India the second-largest consumer of tobacco in the world. Thus, India attributed the highest share of this market in South Asia, which was 29.5% in the year 2021.

Category-wise Insights

What is the global cotinine screening market value?

The global cotinine screening devices market was valued at US$ 429.9 Million in the year 2021 and is expected to expand at a CAGR of 4.7% over the forecast period (2022 to 2032)

Which device holds the highest market share in the global cotinine screening devices market?

Cassettes held a 62.9% market share, by the value of the overall cotinine screening devices market in the year 2021 and are expected to grow at a cumulative CAGR of 5.1% and will record sales worth US$ 645 Million by the end of 2032. Since cassettes are the easiest device to test the presence of cotinine in the human body, they are the most preferred device in the industry. Various rapid testing kits used by workplace screening centers use cassettes as their diagnostic tools.

Which sample type recorded the maximum sales of the global cotinine screening devices market?

Saliva samples attributed 61.0% market share, by the value of the total market in the year 2021 and this segment is expected to expand at a CAGR of 4.8% over the forecast period with anticipated sales worth US$ 382.8 Million by the end of 2029. Consumers prefer this type of sample for testing, which explains the high market share.

Which end-user held the highest market share of the global cotinine screening devices market?

Laboratories held a 38.5% market share, by the value of the global market in the year 2021 with sales recorded worth US$ 165.6 Million in the same year. The laboratories segment is anticipated to expand at a cumulative CAGR of 4.9% over the forecast period. Since there is an influx of funds for the research and development of innovative rapid testing kits, and the rising importance of smoking cessation around the world, laboratories are working round the clock for the same. Thus, they would be growing at a steady pace over the forecast period.

Competitive Landscape

The key players in this market are focusing on exhibiting and showcasing their product lines at various conventions and conferences to gain publicity for their products and thereby expand their businesses.

Nano-Ditech Corporation announced the successful representation of the company’s product lines in the Medlab 2017 held in Dubai from March 6th to 9th.

LifeSign LLC announced its participation in the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in August 2019.

In November 2017, Ameritek USA successfully exhibited their upcoming product line in the Medica 2016 held in Germany.

Hangzhou Clongene Biotech Co., in August 2019 announced that they exhibited their new product lines at the 2019 AACC Annual Scientific Meeting & Clinical Lab Expo.

Continuous efforts taken by various governments to stop the growing burden of smoking tobacco and drug abuse, decreasing the popularity of smoking amongst pregnant women, and growing interest in healthier lives will propel the demand for these screening devices in the upcoming years and present the manufacturers with many lucrative opportunities for growth and development.

Scope of the report

Attributes Details
Forecast Period 2022 to 2032
Historic Data available for 2014 to 2021
Market Analysis USD Million for value
Key Countries covered USA, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, and South Africa.
Key Segments Covered Device Type, Sample Type, End-User & Region
Key Companies Profiled Abbott Laboratories; AlcoPro Inc.; Jant Pharmacal Corporation; Sinocare Inc.,(PTS Diagnostics); Mossman Associates; Nano-Ditech Corp; LifeSign LLC; ALFA Scientific; Ameritek USA.; Hangzhou Clongene Biotech Co.; Germaine Laboratories, Inc.
Report Coverage Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization and Pricing Available upon request

Cotinine Screening Devices Market, By Category

Device Type:

  • Cassettes
  • Strips
  • Reader

By Sample Type:

  • Blood Sample
  • Urine Sample
  • Saliva Sample

By End-User:

  • Hospitals
  • Laboratories
  • Clinics
  • Workplace Screening Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Frequently Asked Questions

What are cotinine screening devices?

Cotinine screening devices are used to detect the presence of nicotine in a person’s body, which depicts the use of tobacco in the recent past.

What are the key market statistics of the global cotinine screening devices market?

The global cotinine screening devices market was valued at US$ 429.9 Million in the year 2021 and is expected to expand at a CAGR of 4.7% over the forecast period (2022 to 2032)

Who are the key players of the cotinine screening devices industry?

The Key players in the Cotinine Screening Devices market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc.

Which device dominates the global cotinine screening devices market?

Cassettes dominate the global cotinine screening devices market with a market share of more than 60% of the overall market in the year 2021.

Table of Content

1. Executive Summary | Cotinine Screening Devices Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Pricing Analysis, by Region

5. Global Market Demand (in Volume Units) Analysis 2014 to 2021 and Forecast, 2022 to 2029

    5.1. Historical Market Volume (Units) Analysis, 2014 to 2021

    5.2. Current and Future Market Volume (Units) Projections, 2022 to 2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market - Pricing Analysis

    6.1. Regional Pricing Analysis by Device Type

    6.2. Pricing Break-up

        6.2.1. Manufacture-level Pricing

        6.2.2. Distributor-level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029

    7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021

    7.2. Current and Future Market Value (US$ Million) and Projections, 2022 to 2029

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Global GDP Growth Outlook

        8.1.2. Global Healthcare Outlook

        8.1.3. Income Per Capita Outlook

        8.1.4. Global Smoking Prevalence

        8.1.5. Economic Impact of Smoking

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Number of Health & Life Insurance Purchases

        8.2.2. Awareness of Cotinine Testing

        8.2.3. Availability of Cotinine Screening Devices

        8.2.4. Cost of Cotinine Screening Devices

        8.2.5. Adoption of Cotinine Screening Devices

    8.3. Market Dynamics

        8.3.1. Drivers

        8.3.2. Restraints

        8.3.3. Opportunity Analysis

9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Device Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Device Types, 2014 to 2021

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Device Type, 2022 to 2029

        9.3.1. Cassettes

        9.3.2. Strips

        9.3.3. Reader

    9.4. Market Attractiveness Analysis By Device Type

10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Sample Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2014 to 2021

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2022 to 2029

        10.3.1. Blood Sample

        10.3.2. Urine Sample

        10.3.3. Saliva Sample

    10.4. Market Attractiveness Analysis By Device Type

11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End Users

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By End Users, 2014 to 2021

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End Users, 2022 to 2029

        11.3.1. Hospitals

        11.3.2. Laboratories

        11.3.3. Clinics

        11.3.4. Workplace Screening Centers

    11.4. Market Attractiveness Analysis By End Users

12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2014 to 2021

    12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Analysis and Volume (Units) By Market Taxonomy, 2014 to 2021

    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        13.3.1. By Country

            13.3.1.1. USA

            13.3.1.2. Canada

        13.3.2. By Device Type

        13.3.3. By Sample Type

        13.3.4. By End Users

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Device Type

        13.4.3. By Sample Type

        13.4.4. By End Users ;

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Rest of Latin America

        14.3.2. By Device Type

        14.3.3. By Sample Type

        14.3.4. By End Users

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Device Type

        14.4.3. By Sample Type

        14.4.4. By End Users

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. United Kingdom

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Device Type

        15.3.3. By Sample Type

        15.3.4. By End Users

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Device Type

        15.4.3. By Sample Type

        15.4.4. By End Users

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Device Type

        16.3.3. By Sample Type

        16.3.4. By End Users

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Device Type

        16.4.3. By Sample Type

        16.4.4. By End Users

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Device Type

        17.3.3. By Sample Type

        17.3.4. By End Users

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Device Type

        17.4.3. By Sample Type

        17.4.4. By End Users

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Device Type

        18.3.3. By Sample Type

        18.3.4. By End Users

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Device Type

        18.4.3. By Sample Type

        18.4.4. By End Users

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2014 to 2021

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2029

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. Northern Africa

            19.3.1.4. South Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Device Type

        19.3.3. By Sample Type

        19.3.4. By End Users

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Device Type

        19.4.3. By Sample Type

        19.4.4. By End Users

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global vs. Country Growth Comparison

    20.2. China Market Analysis

        20.2.1. Introduction

        20.2.2. PEST Analysis

        20.2.3. Market Value Proportion Analysis by Market Taxonomy

        20.2.4. Market Value (US$ Million) and Volume (Units)Analysis and Forecast by Market Taxonomy

            20.2.4.1. By Device Type

            20.2.4.2. By Sample Type

            20.2.4.3. By End-User

        20.2.5. China Competitive Landscape

    20.3. India Market Analysis

        20.3.1. Introduction

        20.3.2. PEST Analysis

        20.3.3. Market Value Proportion Analysis by Market Taxonomy

        20.3.4. Market Value (US$ Million) and Volume (Units)Analysis and Forecast by Market Taxonomy

            20.3.4.1. By Device Type

            20.3.4.2. By Sample Type

            20.3.4.3. By End-User

        20.3.5. India Competitive Landscape

    20.4. Brazil Market Analysis

        20.4.1. Introduction

        20.4.2. PEST Analysis

        20.4.3. Market Value Proportion Analysis by Market Taxonomy

        20.4.4. Market Value (US$ Million) and Volume (Units)Analysis and Forecast by Market Taxonomy

            20.4.4.1. By Device Type

            20.4.4.2. By Sample Type

            20.4.4.3. By End-User

        20.4.5. Brazil Competitive Landscape

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

        21.3.1. By Regional footprint of Players

        21.3.2. Product foot print by Players

        21.3.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Abbott

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. AlcoPro

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Jant Pharmacal Corporation

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Sinocare Inc.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Mossman Associates

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. Nano-Ditech Corp

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. LifeSign LLC

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. ALFA Scientific

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Ameritek USA.

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Hangzhou Clongene Biotech Co.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. Germaine Laboratories, Inc.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Recommendations

Healthcare

Drug of Abuse Testing Market

November 2021

REP-GB-1649

June 2023

306 pages

Healthcare

High Content Screening Market

April 2021

REP-GB-426

May 2023

234 pages

Healthcare

Self-testing Market

September 2020

REP-GB-7914

March 2023

300 pages

Healthcare

Cytotoxic Drugs Market

December 2021

REP-GB-2515

December 2022

322 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Cotinine Screening Devices Market